{"id":"W4399737838","doi":"10.1200/jco.2024.42.16_suppl.3092","title":"Ipatasertib in patients with <i>AKT1/2/3</i> mutation-positive (<i>AKT</i>mut) tumors: TAPISTRY study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; AKT1; Protein kinase B; Mutation; Cancer research; Oncology; Internal medicine; Pathology; Genetics; Phosphorylation; Gene; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001660342,0.0007255967,0.0009504175,0.0002546888,0.0002773561,0.0009668205,0.0004705545,0.0007369751,0.002201894],"category_scores_gemma":[0.000806087,0.0003345579,0.001746482,0.0003929718,0.0004161621,0.0006879593,0.0004995898,0.002208061,0.0007778195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008280926,"about_ca_system_score_gemma":0.001203344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007117562,"about_ca_topic_score_gemma":0.002591296,"domain_scores_codex":[0.9996669,0.0001136742,0.00002142289,0.00007466586,0.0000489786,0.00007435973],"domain_scores_gemma":[0.9994511,0.00007074459,0.0001601294,0.00005848562,0.00004295601,0.000216584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6559463,0.02094358,0.1109508,0.001726922,0.006023214,0.0008273299,0.0005052991,0.003862598,0.03786397,0.0007773432,0.02532637,0.1352462],"study_design_scores_gemma":[0.4496875,0.3248316,0.1825427,0.0002596142,0.005452345,0.002164046,0.000211367,0.003751109,0.006683233,0.0009387924,0.02335913,0.0001185318],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837157,0.004414191,0.0004327638,0.0006060108,0.0001390262,0.001207889,0.004118945,0.00006937024,0.00529609],"genre_scores_gemma":[0.9853911,0.002048805,0.0006914128,0.00147603,0.0002037488,0.0008824606,0.006950553,0.00003112823,0.002324719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002201894,"threshold_uncertainty_score":0.008780837,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0274663434536867,"score_gpt":0.3987068319265859,"score_spread":0.3712404884728992,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}